"We are developing a program of work to support additional indications for Penthrox®. Our longer term ambition is to extend the use of Penthrox® into:
a. post-operative breakthrough pain;
b. breakthrough cancer pain;
c. repeat use scenarios; and ultimately
d. home use."
"We are developing a program of work to support additional...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
0.005(1.10%) |
Mkt cap ! $48.04M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 47.0¢ | 45.5¢ | $19.74K | 42.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18907 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 12513 | 1 |
View Market Depth
| Last trade - 15.47pm 16/08/2024 (20 minute delay) ? |
| MVP (ASX) Chart |